Literature DB >> 8562031

Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.

H Shinoda1, C C Huang.   

Abstract

Intercellular adhesion molecule-1 (ICAM-1) may have a role in acquired cholesteatoma, which is usually associated with an inflammatory reaction occurring in the middle ear cavity. The presence of ICAM-1 in human cholesteatomas was demonstrated by an immunoblotting assay using a specific monoclonal anti-ICAM-1 antibody after protein extraction. Distribution of ICAM-1 in the cholesteatoma tissues was then studied by avidin-biotin-peroxidase complex staining. ICAM-1 appeared to be localized on keratinocytes in all layers of the epithelium and on Langerhans cells in both the epithelium and granulation tissue of cholesteatoma. ICAM-1 was not found in the epidermis of normal external ear canal skin, normal tympanic membrane or normal facial skin, but significant staining was seen on keratinocytes of hair follicles and glands in the facial skin. The present study is the first to demonstrate ICAM-1 in cholesteatoma and suggests that it may have an important role in the clinical development of cholesteatoma, including migration, adhesion and proliferation of lymphocytes, Langerhans cells and keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8562031     DOI: 10.1007/bf00167306

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  26 in total

1.  Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms.

Authors:  A W Boyd; S O Wawryk; G F Burns; J V Fecondo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 2.  The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion.

Authors:  S O Wawryk; J R Novotny; I P Wicks; D Wilkinson; D Maher; E Salvaris; K Welch; J Fecondo; A W Boyd
Journal:  Immunol Rev       Date:  1989-04       Impact factor: 12.988

3.  Experimental induction of middle ear cholesteatoma in rats.

Authors:  C C Huang; G S Shi; Z X Yi
Journal:  Am J Otolaryngol       Date:  1988 Jul-Aug       Impact factor: 1.808

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1).

Authors:  S D Marlin; T A Springer
Journal:  Cell       Date:  1987-12-04       Impact factor: 41.582

6.  Third place--Resident Basic Science Award 1990. Interleukin 1 causing bone destruction in middle ear cholesteatoma.

Authors:  J M Ahn; C C Huang; M Abramson
Journal:  Otolaryngol Head Neck Surg       Date:  1990-10       Impact factor: 3.497

7.  Localization of interleukin-1 in human cholesteatoma.

Authors:  J M Ahn; C C Huang; M Abramson
Journal:  Am J Otolaryngol       Date:  1990 Mar-Apr       Impact factor: 1.808

8.  Intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigens in herpes keratitis.

Authors:  V M Elner; S Dutt; M A Pavilack; A Sugar; C S Foster; S G Elner
Journal:  Ophthalmology       Date:  1992-09       Impact factor: 12.079

9.  Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor.

Authors:  C E Griffiths; J J Voorhees; B J Nickoloff
Journal:  J Am Acad Dermatol       Date:  1989-04       Impact factor: 11.527

10.  Colony-stimulating factor in middle ear cholesteatoma.

Authors:  T Huang; S D Yan; C C Huang
Journal:  Am J Otolaryngol       Date:  1989 Nov-Dec       Impact factor: 1.808

View more
  2 in total

1.  Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.

Authors:  Hans-J Welkoborsky; Roland S Jacob; Mike L Hinni
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-01       Impact factor: 2.503

Review 2.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.